Background: Tuberculosis (TB) remains a significant global health threat, with treatment often complicated by adverse drug reactions (ADRs). These reactions can lead to treatment non-adherence, increased healthcare costs, and unfavorable patient outcomes. While the prevalence of ADRs in India is documented, local data regarding their pattern and severity in specific peripheral settings are often limited. The study aimed to examine the pattern, severity, causality, and preventability of ADRs associated with anti-tuberculosis drugs at a tertiary care hospital. Methods: A prospective observational study was conducted over six months involving 74 patients who experienced a total of 108 ADRs. Data were collected using a suspected adverse drug reaction reporting form. Assessment scales included the WHO-UMC scale for causality, the Modified Hartwig and Siegel Scale for severity, and the Modified Schumock and Thornton scale for preventability. Results: The mean age of patients was 34.03 ± 14.43 years, with a male predominance (56.74%). The Gastrointestinal system was the most frequently affected (37.04%), followed by the Hepatobiliary system (16.67%). Severity assessment showed that 86% of ADRs were mild, 12% were moderate, and 2% were severe. Causality assessment categorized 92% of reactions as "Possible" and 8% as "Probable". Furthermore, 67.3% of ADRs were found to be non-preventable. Management of these reactions required the permanent withdrawal of the suspected drug in 43.24% of cases. Conclusion: ADRs are common during anti-tubercular therapy, primarily affecting the gastrointestinal and hepatobiliary systems. Although most reactions are mild, the frequent need for drug withdrawal underscores the importance of continuous ADR surveillance and prompt management to ensure treatment adherence and successful outcomes.